Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo
- DOI
- 10.1007/s13555-026-01724-y
- Published
- 2026-05-22
- Container
- Dermatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-026-01724-y,
title = {Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo},
author = {Tatjana Lukic and Pranab Ghosh and Lynne Napatalung and Cunshan Wang and Samantha K. Kurosky and Iltefat Hamzavi and Rodney Sinclair and Leihong Xiang and Kenneth Steil and David Rosmarin and Davinder Parsad and Khaled Ezzedine and Roni Adiri},
year = {2026},
journal = {Dermatology and Therapy},
doi = {10.1007/s13555-026-01724-y},
url = {https://doi.org/10.1007/s13555-026-01724-y}
}RIS
TY - JOUR TI - Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo AU - Tatjana Lukic AU - Pranab Ghosh AU - Lynne Napatalung AU - Cunshan Wang AU - Samantha K. Kurosky AU - Iltefat Hamzavi AU - Rodney Sinclair AU - Leihong Xiang AU - Kenneth Steil AU - David Rosmarin AU - Davinder Parsad AU - Khaled Ezzedine AU - Roni Adiri PY - 2026 JO - Dermatology and Therapy DO - 10.1007/s13555-026-01724-y UR - https://doi.org/10.1007/s13555-026-01724-y ER -
APA
Lukic, T., Ghosh, P., Napatalung, L., Wang, C., Kurosky, S. K., Hamzavi, I., Sinclair, R., Xiang, L., Steil, K., Rosmarin, D., Parsad, D., Ezzedine, K., & Adiri, R. (2026). Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01724-y
Source records
- crossref · retrieved 2026-09-25T20:26:16.851Z